- Home
- PYPD vs BCG Comparison
PYPD vs BCG Comparison
Compare PYPD & BCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- BCG
- Stock Information
- Founded
- PYPD 2008
- BCG 2016
- Country
- PYPD Israel
- BCG United States
- Employees
- PYPD N/A
- BCG N/A
- Industry
- PYPD Medical/Dental Instruments
- BCG
- Sector
- PYPD Health Care
- BCG
- Exchange
- PYPD Nasdaq
- BCG Nasdaq
- Market Cap
- PYPD 34.8M
- BCG 32.5M
- IPO Year
- PYPD 2020
- BCG N/A
- Fundamental
- Price
- PYPD $3.49
- BCG $1.74
- Analyst Decision
- PYPD Strong Buy
- BCG
- Analyst Count
- PYPD 5
- BCG 0
- Target Price
- PYPD $12.00
- BCG N/A
- AVG Volume (30 Days)
- PYPD 52.0K
- BCG 24.3K
- Earning Date
- PYPD 11-12-2025
- BCG 11-13-2025
- Dividend Yield
- PYPD N/A
- BCG N/A
- EPS Growth
- PYPD N/A
- BCG N/A
- EPS
- PYPD N/A
- BCG N/A
- Revenue
- PYPD N/A
- BCG $173,961,000.00
- Revenue This Year
- PYPD N/A
- BCG N/A
- Revenue Next Year
- PYPD N/A
- BCG N/A
- P/E Ratio
- PYPD N/A
- BCG N/A
- Revenue Growth
- PYPD N/A
- BCG 7.45
- 52 Week Low
- PYPD $2.30
- BCG $1.45
- 52 Week High
- PYPD $3.93
- BCG $6.55
- Technical
- Relative Strength Index (RSI)
- PYPD 54.23
- BCG 44.41
- Support Level
- PYPD $3.35
- BCG $1.75
- Resistance Level
- PYPD $3.54
- BCG $2.10
- Average True Range (ATR)
- PYPD 0.12
- BCG 0.15
- MACD
- PYPD 0.00
- BCG -0.01
- Stochastic Oscillator
- PYPD 75.49
- BCG 44.38
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About BCG Binah Capital Group Inc. Common Stock
Binah Capital Group Inc formerly Wentworth Management Services LLC is a holding company that acquires and manages businesses in the wealth management industry. The company specializes in consolidating independent broker-dealers to capture economies of scale needed to service financial advisors in today's technology-enabled regulatory environment. Wentworth's core philosophy focuses on building long-term, productive relationships with its advisor base.